SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001730463-23-000115
Filing Date
2023-11-27
Accepted
2023-11-27 07:07:52
Documents
16
Period of Report
2023-11-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K autl-20231127.htm   iXBRL 8-K 30909
2 EX-99.1 pressreleasedatednovembe.htm EX-99.1 8332
6 pressreleasedatednovembe001.jpg GRAPHIC 222482
7 pressreleasedatednovembe002.jpg GRAPHIC 298687
8 pressreleasedatednovembe003.jpg GRAPHIC 63430
  Complete submission text file 0001730463-23-000115.txt   978264

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT autl-20231127.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT autl-20231127_lab.xml EX-101.LAB 24717
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT autl-20231127_pre.xml EX-101.PRE 13007
10 EXTRACTED XBRL INSTANCE DOCUMENT autl-20231127_htm.xml XML 2848
Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38547 | Film No.: 231437308
SIC: 2836 Biological Products, (No Diagnostic Substances)